Inhalable Cannabis Formulation Kit with Segmented Dosing

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

The existing methods for creating and delivering inhalable cannabinoid formulations for aerosol devices are inefficient and lack quality control, leading to suboptimal vaping experiences and potential contamination due to the fragmentation of state laws and regulations, as well as the reliance on black market sources for cartridges and inputs, resulting in mislabeling and waste.

Innovation Solution

A kit system that includes pre-measured active and inactive agents, optimized filling stations, and customizable labeling for creating specific cannabinoid formulations, allowing for accurate and controlled delivery of medicinal cannabis compounds, enabling users to create and refill cartridges with verified ingredients and precise dosing.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Adaptability or versatility

If traditional black market sources are used for cartridges and inputs, then availability is improved, but quality control and reliability deteriorate due to mislabeling and contamination

Engineering Contradiction:
ImproveavailabilityVSAvoidquality control
Core Design Contradiction:
Adaptability or versatilityVSReliability

Solution Approach 1:

The kit divides the formulation process into separate, pre-measured components (active agents in separate containers, inactive agents in separate containers) that are combined by the user. This segmentation ensures each component can be independently verified for quality and purity, preventing contamination while maintaining availability through standardized packaging.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The kit acts as an intermediary between regulated cannabinoid sources and the final inhalable product. By providing pre-measured, verified ingredients in a controlled packaging system with instructions, the kit ensures quality control at each stage while making the process accessible to users who need reliable medicinal cannabis compounds.

Inventive Principle:
Principle #24Intermediary (Mediator)

2Ease of operation

If manual formulation methods are used, then flexibility is improved, but manufacturing precision deteriorates due to lack of quality control

Engineering Contradiction:
ImproveflexibilityVSAvoiddosing accuracy
Core Design Contradiction:
Ease of operationVSManufacturing precision

Solution Approach 1:

The kit provides pre-measured active agents and inactive agents in separate containers before the user begins formulation. This preliminary measurement ensures precise dosing and consistent formulation ratios, eliminating the need for users to manually measure ingredients while maintaining flexibility in creating different cannabinoid formulations.

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The kit enables users to change formulation parameters (cannabinoid ratios, flavors, textures) by selecting different pre-measured active and inactive agent combinations. The standardized packaging maintains manufacturing precision while allowing flexibility in adjusting formulation characteristics to meet different medicinal needs.

Inventive Principle:
Principle #35Parameter changes

3Adaptability or versatility

If custom formulation processes are developed, then product specificity is improved, but device complexity increases due to multiple inputs and procedures

Engineering Contradiction:
Improveproduct specificityVSAvoidprocess complexity
Core Design Contradiction:
Adaptability or versatilityVSDevice complexity

Solution Approach 1:

The kit merges multiple components (active agents, inactive agents, mixing instructions, labeling templates) into a single integrated packaging system. This consolidation simplifies the overall process for users while maintaining the ability to create specific custom formulations by selecting and combining different pre-measured ingredients according to the provided instructions.

Inventive Principle:
Principle #5Merging (Combining)

4Ease of manufacture

If traditional filling methods are used, then ease of manufacture is improved, but productivity deteriorates due to inefficiency and waste

Engineering Contradiction:
Improveease of fillingVSAvoidproduction efficiency
Core Design Contradiction:
Ease of manufactureVSProductivity

Solution Approach 1:

The kit provides pre-measured inactive agents and active agents in ready-to-use containers with appropriate packaging for efficient transfer to cartridges. This preliminary preparation eliminates time-consuming manual measurement and reduces material waste, improving both ease of manufacture and production efficiency for users creating inhalable formulations.

Inventive Principle:
Principle #10Preliminary action

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This solution streamlines the production and delivery of inhalable formulations, reducing waste and ensuring accurate dosing, while providing a cost-effective and quality-controlled method for both medicinal and recreational users, addressing the inefficiencies and regulatory challenges in the current market.

Implementation Method 1

an atomizer which serves as the heating element responsible for atomizing the formulation into an inhalable mist

Methodology Applied
Scientific EffectVaporization: Evaporation

Implementation Method 2

a battery unit that provides power to the atomizer, which contains a coil that heats up and volatizes the formulation into an inhalable mist

Methodology Applied
Scientific EffectHeating: Heating

Implementation Method 3

The wick can be made from material adaptable to facilitate transport of the formulation (usually a liquid) from the reservoir to the heating chamber, via capillary action for example

Methodology Applied
Scientific EffectCapillary action: Capillary Action

Data Source

PatentUS11690890B2Kits for manufacturing inhalable formulations of medicinal cannabis compounds for aerosol devices, apparatuses, and methods for making and using the same
Publication Date: 2023.07.04 NIEBLING AVRAM
  • US11690890B2 patent drawing
  • US11690890B2 patent drawing
  • US11690890B2 patent drawing

AI summary

Kits enabling an end user to efficiently compound inhalable formulations containing medicinal compounds, for use in in aerosol device (e-cigarette; personal vaporizer). Kits include a reusable storage device, a filling station, at least one predetermined amount aerosol precursor in a container and at least one empty cartomizer (cartridge) for use in an aerosol delivery device. Optionally, kits may also include a predetermined amount of extract containing a known amount of medicinal compound, enabling the production of an amount an inhalable formulation. Optionally, kits may contain amounts of inputs that enable the refilling/reuse of cartridges.